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A class-contrastive human-interpretable machine learning
approach to predict mortality in severe mental illness
Soumya Banerjee 1✉, Pietro Lio2, Peter B. Jones 1,3 and Rudolf N. Cardinal 1,3
Machine learning (ML), one aspect of artificial intelligence (AI), involves computer algorithms that train themselves. They have been
widely applied in the healthcare domain. However, many trained ML algorithms operate as ‘black boxes’, producing a prediction
from input data without a clear explanation of their workings. Non-transparent predictions are of limited utility in many clinical
domains, where decisions must be justifiable. Here, we apply class-contrastive counterfactual reasoning to ML to demonstrate how
specific changes in inputs lead to different predictions of mortality in people with severe mental illness (SMI), a major public health
challenge. We produce predictions accompanied by visual and textual explanations as to how the prediction would have differed
given specific changes to the input. We apply it to routinely collected data from a mental health secondary care provider in patients
with schizophrenia. Using a data structuring framework informed by clinical knowledge, we captured information on physical
health, mental health, and social predisposing factors. We then trained an ML algorithm and other statistical learning techniques to
predict the risk of death. The ML algorithm predicted mortality with an area under receiver operating characteristic curve (AUROC)
of 0.80 (95% confidence intervals [0.78, 0.82]). We used class-contrastive analysis to produce explanations for the model predictions.
We outline the scenarios in which class-contrastive analysis is likely to be successful in producing explanations for model
predictions. Our aim is not to advocate for a particular model but show an application of the class-contrastive analysis technique to
electronic healthcare record data for a disease of public health significance. In patients with schizophrenia, our work suggests that
use or prescription of medications like antidepressants was associated with lower risk of death. Abuse of alcohol/drugs and a
diagnosis of delirium were associated with higher risk of death. Our ML models highlight the role of co-morbidities in determining
mortality in patients with schizophrenia and the need to manage co-morbidities in these patients. We hope that some of these bio-
social factors can be targeted therapeutically by either patient-level or service-level interventions. Our approach combines clinical
knowledge, health data, and statistical learning, to make predictions interpretable to clinicians using class-contrastive reasoning.
This is a step towards interpretable AI in the management of patients with schizophrenia and potentially other diseases.
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INTRODUCTION
In this article we apply a recent development in machine learning,
termed class-contrastive analysis, to the major public health
problem of premature mortality in schizophrenia. Schizophrenia
affects approximately 0.5% of the population1. It is a severe
mental illness (SMI), along with bipolar affective disorder,
personality disorders, and recurrent depressive disorder. Patients
with schizophrenia or other SMI more broadly have substantially
increased mortality and reduced life expectancy, often due to
physical co-morbidities2–5. A challenge for clinical practice is
therefore to identify patients at particularly high risk of adverse
events (including premature death) and seek to intervene early.
Machine learning (ML) offers a potential route to risk prediction
in the field of SMI as elsewhere. ML, a sub-field of artificial
intelligence (AI), involves computer algorithms that automatically
adjust in response to training data (‘train themselves’). Their
attractiveness relates to their ability to create predictive models
from complex data sets with minimal human intervention, to a
degree that may exceed the accuracy of classical statistical models
such as logistic regression. ML achieves this through a variety of
techniques. In a basic technique such as a multi-layer artificial
neural network, for example, a layer of hidden nodes is trained by
the algorithm to respond to weighted combinations of inputs;
there may be further such layers responding to weighted
combinations of the first layer, and these layers may interact
recurrently. The “output" layer, giving the prediction or classifica-
tion, responds to weighted combinations of preceding nodes. The
algorithm seeks to minimize output prediction error. As a result,
the output may predict accurately (if validated on independent
data to avoid overfitting), but it may be very hard for a human to
discern how the decision was reached. Clinically, it may be
impractical to rely on such a black box predictor.
Here, we develop ML models of mortality in schizophrenia and
apply the technique of class-contrastive reasoning to improve
their explicability. Class-contrastive reasoning is a technique from
the social sciences6,7: the contrast is to an alternative class of
exemplars. An example of a class-contrastive explanation is: ‘The
selected patient is at high risk of mortality because the patient has
dementia in Alzheimer’s disease and has cardiovascular disease. If
the patient did not have both of these characteristics, the
predicted risk would be much lower.’
We apply an ML and class-contrastive framework to data on
clinically relevant bio-social variables spanning physical health,
mental health, personal history, and social predisposing factors.
We collate this information from an electronic clinical records
system and use clinician knowledge to transform them into
features that are used to train an ML system (Fig. 1). We use the
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ML model to predict mortality and apply class-contrastive
reasoning to explain the model.
We also use a visualization technique for machine learning
models (class-contrastive heatmaps) that allows us to map the
effect of changing a set of features.
Our approach can be helpful when explicit causal structure is
modelled, and when there are a few features that are binary
(categorical) in nature. Our approach may not be successful when
there are continuous features or many features (hundreds). If
features are hard to define and have to be discovered (for
example, by semi-supervised techniques), our approach may not
be helpful. Most of our features are binary (categorical) in nature
and hence the class-contrastive approach could be applied
successfully.
The class-contrastive approach may also be used to evaluate
the practical limits of explainability of some models. For example,
if a model has hundreds or thousands of features, it may be
computationally intractable to exhaustively explore how changing
combinations of these features affects the model output.
Our aim is not to advocate for a particular statistical model or
black box model. Our objective is to give an example of how
class contrastive reasoning can be used to explain black
box models with binary categorical features in real-world
electronic healthcare record data, in a disease of public health
significance.
Our aim is not to exhaustively compare all possible statistical
models but merely briefly survey and analyse some techniques.
We note that our aim is not to demonstrate that some machine
learning models can perform better than others.
We show a practical demonstration on a clinical dataset in a
disease of public health relevance. We also outline the instances in
which class-contrastive reasoning can be successfully applied to
electronic health care record data. We suggest class-contrastive
reasoning as a method to begin understanding ML and statistical
models that have non-linearities. To the best of our knowledge
this is the first application of this technique to real world
electronic healthcare record data.
Our work is a step towards personalised medicine and
interpretable AI in mental health and has the potential to be
applicable more broadly in healthcare.
RESULTS
Summary of results
We used a range of statistical and ML techniques to predict
mortality in patients with schizophrenia. Class-contrastive reason-
ing and class-contrastive heatmaps were used to generate human-
oriented explanations of statistical and ML model predictions.
Abuse of alcohol and drugs, and a diagnosis of delirium were
risk factors for mortality (across all our techniques). The use of
antidepressants was associated with lower risk of death via all our
techniques.
The machine learning models emphasized combinations of
features (like Alzheimer’s disease) with other co-morbidities. This
highlights the role of co-morbidities in determining mortality in
patients with SMI and the need to manage these co-morbidities.
Survival analysis and standardized mortality ratios
Our explainable machine learning techniques complement
classical statistical analysis like survival models and standardised
mortality ratios. In this section, we outline these approaches.
For survival analysis, we use age (feature scaled) and the bio-
social features (as outlined in Subsection Data input to statistical
algorithms) as input features for patients with schizophrenia. For
patients with schizophrenia, we show the hazard ratios associated
with each feature in Fig. 2 using a Cox proportional hazards
model. The use of second-generation antipsychotics (SGA) and
antidepressants was associated with reduced risk of death in
patients with schizophrenia. Alcohol/substance abuse was asso-
ciated with an elevated risk of death consistent with a previous
study8. A diagnosis of delirium was similarly associated with
increased mortality.
The standardized mortality ratio (SMR) for patients with
schizophrenia was 7.4 (95% confidence interval: [5.5, 9.2]). This is
consistent with SMRs reported in the UK8.
Logistic regression models
We used a logistic regression model to predict mortality in
patients with schizophrenia. We show the odds ratios and their
confidence intervals in Fig. 3. Age, diagnosis of delirium and

























Feedback to patients, clinicians and data scientists
“Patient is predicted to have an 
elevated risk of mortality because of 
dementia and cardiovascular disease” 
Fig. 1 Overview of approach. Bio-social factors that are relevant in severe mental illnesses (SMI) are derived from the electronic healthcare
record system and used as inputs to statistical and machine learning algorithms. The algorithms are made interpretable using class-
contrastive reasoning. The class-contrastive textual statements and heatmaps aid the understanding of models by domain experts such as
clinicians, patients, and data scientists.
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(1.11 −  2.56)
(0.53 −  1.27)
(0.68 −  1.84)
(0.87 −  1.75)
(0.82 −  2.25)
(0.47 −  1.95)
(0.29 −  2.38)
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(0.33 −  0.70)
(0.37 −  0.79)
(0.25 −  1.65)
(0.92 − 11.26)
(0.64 −  8.40)
(0.26 −  2.54)
(0.54 −  4.42)
(0.20 −  3.52)
(0.24 −  2.61)
(1.04 −  2.85)
(1.24 −  5.01)
(0.64 −  5.75)






















# Events: 175; Global p−value (Log−Rank): 5.6118e−34 
AIC: 2271.34; Concordance Index: 0.78
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Hazard ratio and 95% confidence interval
p-valuelower mortality excess mortality
Fig. 2 Survival analysis for patients with schizophrenia using a Cox proportional hazards model. We show the hazard ratios associated
with each feature and the confidence intervals. Use of second-generation antipsychotics (SGA) and antidepressants was associated with
reduced risk of death in patients with schizophrenia. Alcohol/substance abuse and a diagnosis of delirium were associated with increased
mortality. FGA: first-generation antipsychotics.
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Use of second-generation antipsychotics and antidepressants
were associated with a reduced risk of death.
Class-contrastive heatmaps and counter-factual statements
for logistic regression
The class-contrastive explanatory technique is applicable to
machine learning models and statistical models such as logistic
regression. We first demonstrate our approach by using class-
contrastive reasoning on the logistic regression model for
predicting mortality. We show the amount of change (predicted
by the trained logistic regression model on the test set) in the
probability of death by changing one particular feature from 0 to 1
(in the test set). We visualize this using a heatmap (Fig. 4) where
rows represent patients and columns represent features in the test
set that have been changed. Predictions are made using the
trained logistic regression model on the test set.
The class-contrastive heatmap shows patient-specific predic-
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Fig. 3 Logistic regression model to predict mortality in patients with schizophrenia. Log odds ratio of features in a logistic regression
model to predict mortality in patients with schizophrenia. Shown are confidence intervals and statistical significance (filled dark circles:
p-value < 0.05, open circles: not significant). Age, alcohol/substance abuse and a diagnosis of delirium were associated with a high risk of
death. The use of second-generation antipsychotics (SGA) and antidepressants were associated with reduced risk of death.
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way: the trained logistic regression model makes a prediction for
the probability of death based on the modified features as input.
This process is repeated for each patient and each feature.
We observe that a diagnosis of delirium or dementia predis-
poses a group of patients towards a higher probability of
predicted mortality (Fig. 4). Patients (with schizophrenia) who
were taking antidepressants were less likely to die during the
period observed (Fig. 4). The class-contrastive and counterfactual
analysis suggests that antidepressants may be associated with
lower mortality in a group of patients (Fig. 4).
The heatmap also highlights counter-intuitive predictions. For
example, the heatmap suggests that there is a small sub-group of
patients (Fig. 4: top left hand corner indicated with an arrow) who
have diabetes and have a lower risk of death. The use of a
probability scale illustrates that the effect of each predictor varies
in terms of its effect on probability (according to the baseline
probability determined by other variables); of course, in log odds
terms, changes in a given predictor will have a constant effect
across all subjects.
We note that the counter-intuitive observations we observe in
the class-contrastive heatmaps (on the test set) may also be as a
result of imbalances in the training set. For example, a particular
binary feature may be 0 for 100 patients and 1 for 10 patients.
In order to address this, we can add synthetic training data with
these imbalances and visualize the class-contrastive predictions
on the test set. We can artificially introduce an imbalance (for
example, add more zeros than ones to a binary feature) in the test
set and training set, and then observe the class contrastive
heatmaps.
We note that age is a predictor in all models that we use.
However, the class-contrastive heatmaps do not include age. This
is because the class-contrastive analysis changes features one at a
time (or pairwise), and this can be achieved only for binary
categorical features. Hence, the class-contrastive heatmaps show
the effect of changing predictors on the model predicted
probability of mortality, over and above the contribution of age.
Class-contrastive analysis for machine learning models
We used artificial neural networks to predict mortality in patients
with schizophrenia. We performed class-contrastive analysis for





































Patients on antidepressants predicted
to have lower risk of death
Patients with delirium or dementia 
predicted to have higher risk of death
Fig. 4 Class-contrastive heatmap for the logistic regression model. Visualization of the amount of change predicted in the probability of
death by setting a particular feature to 1 versus 0 (using a logistic regression model). Rows represent patients and columns represent features.
Predictions are made on the test set using the trained logistic regression model. The arrows indicate groups of patients with low predicted risk
of death (shown in blue on the heatmap) and high predicted risk of death (shown in red). The arrow on the top left indicates a group of
patients having a counter-intuitive characteristic of having diabetes and still have low predicted risk of death. The second arrow on the top
left indicates another group of patients on antidepressants. These patients are predicted (using the logistic regression model) to have a lower
risk of death. There is a third group of patients with delirium or dementia in Alzheimer’s disease (shown with an arrow) who are predicted to
have a higher risk of death. The heatmap also shows a hierarchical clustering dendrogram which is performed using an Euclidean distance
metric and complete linkage. FGA: first-generation antipsychotics, SGA: second-generation antipsychotics.
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We first show a heatmap for a simple version of class-
contrastive reasoning where we mutate only one feature at a
time on the test set (Fig. 6). We show the amount of change
(predicted by the trained model on the test set) in the probability
of death by setting one particular feature to 1 versus 0. We
visualize this using a heatmap as before, where rows represent
patients and columns represent features. We note that even
though we cluster the features, our aim is not to demonstrate any
similarity between them.
The heatmap suggests there is a subgroup of patients in whom
use or prescription of medications like second-generation
antipsychotics (SGA) and antidepressants is associated with a
Fig. 5 Architecture of autoencoder. The autoencoder takes as input the bio-social features. The output layer is used to reconstruct the input.
The hidden layer of the autoencoder is used for dimensionality reduction. We use the hidden layer as input to a random forest model to
predict mortality. The hidden layer is composed of 10 neurons.
Counter-intuitive examples of patients with 
respiratory disease and Alzheimer’s disease
predicted to have lower risk of death
Counter-intuitive examples of patients with 
respiratory disease and Alzheimer’s disease
predicted to have lower risk of death
0.4 -0.4-0.20.2
Patients on second generation antipsychotics 
predicted to have lower risk of death
Patients on antidepressants 
predicted to have lower risk of death
Fig. 6 Class-contrastive heatmap for the deep learning model. Visualization of the amount of change predicted in the probability of death
by setting a particular feature to 1 versus 0. Predictions are made on the test set using a random forest model built on top of the autoencoder.
Columns represent patients and rows represent features. The arrows at the top indicate counter-intuitive examples. If these patients had a
respiratory disease or Alzheimer’s disease, the model predicts low risk of death. The arrows at the bottom indicate a group of patients on
antidepressants and SGA who are predicted to have low risk of death. The heatmap also shows a hierarchical clustering dendrogram, which is
performed using an Euclidean distance metric and complete linkage. We note that even though we cluster the features (columns) we do not
aim to imply any similarity between them. FGA: first-generation antipsychotics.
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lower risk of death (Fig. 6). There is another subgroup of patients
in whom personal risk factors (ICD-10 coded diagnosis; see
‘Methods’) are associated with increased risk of mortality.
The class-contrastive heatmaps also reveal counter-intuitive
aspects of the data and model. Looking at the effect of individual
features in isolation in Fig. 6, we observe small sub-groups of
patients in whom having respiratory diseases or having Alzhei-
mer’s disease is associated with a lower risk of death (indicated
with arrows in Fig. 6).
These counter-intuitive results may be due to the fact that the
class-contrastive approach is sensitive to the training data and any
imbalances in features. For example, a binary feature may have
mostly zeros in the training set. This can lead to a counter-intuitive
result on the test set. Correlations across features may also help
explain these counter-intuitive results.
We show an additional representative class-contrastive heat-
map for the ML model in the Supplementary section (Supple-
mentary Fig. 1). This ML model was run using a different split of
the training and test data. This heatmap is consistent with
previous results (Fig. 6), with the exception that it shows SGA are
associated with an increased probability of mortality (Supplemen-
tary Fig. 1, bottom left arrow). This is not consistent with previous
results from the logistic regression model and survival analysis for
the effect of SGA (Figs. 2 and 3).
Deep learning models combine input features to create higher-
order representations using hidden layers. Features are also often
correlated and there are non-linearities involved. To account for
some higher-order (non-linear) correlations and to better highlight
the combinations of features, we simultaneously change all
possible combinations of two features from 0 to 1 (in the test
set). Specifically, we set a particular combination of two features to
1 simultaneously (versus 0) in the test set. We then repeat this for
all possible pairs of features in the test set. We visualize the
change in model output on the test set in Fig. 7. This technique
can be used to investigate the role of combinations of different
features that deep learning models exploit to build higher-order
representations.
We found combinations of cardiovascular disease and use of
diuretics. Diuretic use was associated with lower risk of mortality in
a group of patients with cardiovascular disease (shown in the blue
region of the heatmap in the lower right-hand corner which is the
region of greatest decrease in predicted probability of death) (Fig.
7). There are also combinations of delirium and dementia in
Alzheimer’s disease that predispose some patients towards
greater risk of mortality (shown in the lower left region of the
heatmap in red) (Fig. 7).
Other co-morbidities that are together associated with greater
mortality in a sub-group of patients (Fig. 7) included: dementia in
Alzheimer’s disease with an additional coded diagnosis of
cardiovascular disease, and dementia in Alzheimer’s disease with
a coded history of abuse of alcohol and drugs.
This highlights the role of co-morbidities in determining
mortality in a sub-group of patients with SMI and the need for
multiple conditions to be managed simultaneously in patients. A
class-contrastive statement for one of these patients in this sub-
group (Fig. 7) is: ‘The selected patient is at high risk of mortality
because the patient has dementia in Alzheimer’s disease and has
cardiovascular disease. If the patient did not have both of these
characteristics, the predicted risk would be much lower.’
Our deep learning models emphasize combinations of different
features. Therefore, as a very simple approximation, we also fit a
more complex logistic regression model with interaction effects.
We fit a logistic regression model with main effects and an
interaction term between dementia in Alzheimer’s disease and
cardiovascular disease (Supplementary Fig. 2). The log-odds ratio
for this interaction term is greater than 0 although it is not
statistically significant. This may suggest that there is only a small
sub-group of patients in whom dementia and cardiovascular
disease co-occur and predispose towards an increased risk of
death. Additional details are available in the Supplementary
Section.
Performance
We show the predictive performance of each model in this
section. The models we used to predict mortality are:
1. A logistic regression model with the bio-social features as
input. The area under receiver operating curve (AUC) from
the logistic regression model was 0.68 (95% confidence
interval [0.65, 0.70]).
2. An autoencoder with the bio-social features as input. We
then used the reduced dimensions from the autoencoder as
input features to a random forest model. The predicted AUC
from random forests built on top of the autoencoder-
reduced dimensions was 0.80 (95% confidence interval
[0.78, 0.82]).
We also use other statistical learning techniques to predict
mortality and these are discussed in the Supplementary section
(Section Additional analysis). We do not aim to exhaustively
compare all possible statistical models but merely briefly survey
and analyse some techniques. Our aim is to apply class-contrastive
analysis to a machine learning model and show that in some
scenarios the model predictions can be explained. We note that
our aim is not to demonstrate that some machine learning models
can perform better than others.
DISCUSSION
Mortality among patients with severe mental illnesses (SMI) is too
often premature3,4. Routinely collected clinical data can help
generate insights that can result in more effective treatment of
these patients.
We used routinely collected clinical data in an observational
study to answer questions of mortality in patients with schizo-
phrenia. We implemented an interpretable computational frame-
work for integrating clinical data in mental health and
interrogating it with statistical and machine learning techniques.
Our framework starts with a database that is a knowledge
repository of expertise. This database was created based on
consultations with clinicians and maps low-level features (for
example, medications such as simvastatin) to broader categories
(for example, cardiovascular medication). These features are
relevant for patients with schizophrenia and were used to predict
mortality.
Our architecture captures clinical information on physical
health, mental health, personal history and social predisposing
factors to create a profile for a patient. We then used a number of
statistical and machine learning techniques to predict mortality
using these features.
We make our predictions interpretable by using class-
contrastive reasoning6,7. Our approach has similarities to case-
based reasoning9 and analogy-based reasoning10, where predic-
tions are made based on similar patient histories cases. The
approach presented here complements other techniques like
Shapley explanations that are used to improve the interpretability
of machine learning models. Further work is required to ensure
the findings from schizophrenia generalise to other types of SMI.
We used a range of statistical and machine learning techniques
to predict mortality in patients with schizophrenia. Since machine
learning models may also be difficult to explain, we make them
explainable using class-contrastive reasoning and class-contrastive
heatmaps.
In patients with schizophrenia, abuse of alcohol and drugs, and
a diagnosis of delirium were risk factors for mortality (across
all techniques). Use or prescription of antidepressants and
S. Banerjee et al.
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Fig. 7 Advanced class-contrastive heatmap for the deep learning model. Class-contrastive heatmap for deep learning models showing the
effect of combinations of features. Visualization of the amount of change predicted in the probability of death by setting a particular
combination of two features to 1 simultaneously (versus 0). Rows represent patients and columns represent feature groupings (all
combinations of two features). Predictions are made on the test set using a random forest model built on top of the autoencoder. Delirium
and dementia in Alzheimer’s disease seem to predispose some patients towards greater risk of mortality (shown in the lower left region of the
heatmap in red). Diuretics appear to be associated with lower mortality in a group of patients with cardiovascular disease (shown in the blue
region in the lower right-hand corner of the heatmap). The heatmap also shows a hierarchical clustering dendrogram which is performed
using an Euclidean distance metric and complete linkage.
S. Banerjee et al.
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second-generation antipsychotics (SGA) were associated with
lower mortality in our logistic regression and survival models.
However, use or prescription of SGA was associated with an
increased probability of mortality in one of our ML models.
The logistic regression model predicted that Alzheimer’s disease
is a risk factor for mortality. The deep learning model emphasized
Alzheimer’s disease in combination with other co-morbidities. This
highlights the role of co-morbidities in determining mortality in
patients with SMI and the need to manage them.
The class-contrastive and survival analysis suggest that anti-
depressants are associated with lower mortality in a group of
patients with schizophrenia. Alcohol/substance misuse was
consistently associated with elevated mortality, suggesting the
requirement to address the needs of so-called “dual diagnosis"
patients (with SMI and comorbid substance misuse) as part of a
strategy to improve life expectancy in patients with SMI.
The association between delirium and excess mortality is
notable but not unexpected2–4. A weakness of the current family
of models is their lack of temporal structure (for example,
consideration of the time between delirium and death) but this
finding serves to emphasize that delirium should not be taken
lightly.
The association of antidepressant use with reduced mortality
was unexpected but consistent across analytical methods. Our
data do not support a mechanistic interpretation (for example,
mode of death is not recorded in these structured clinical records)
but this question would bear further investigation.
Illicit substance abuse and lack of family involvement was
associated with increased risk of mortality8. Alcohol/substance
abuse was also pointed out as a critical factor in our class-
contrastive reasoning analysis and survival analysis. Provisioning
of family support and involving family members and carers could
be part of health management plans11.
We hope that some of these bio-social factors can be targeted
therapeutically by either patient-level interventions (like provi-
sioning of family support11) or service-level improvements12.
Overall, we observed that abuse of alcohol and drugs and a
diagnosis of delirium are risk factors for mortality (in both logistic
regression models and survival models). The use of SGA and
antidepressants were associated with lower mortality from both
our logistic regression models and survival models. This may be
important given that some clinicians may hesitate to prescribe
given what is known about short- to medium-term side effects of
these drugs that include adverse impact on cardiovascular risk
profiles. While our findings on this and other points is not
conclusive evidence of causality, it is in accord with observational
clinical data at the national level13.
The machine learning model emphasized (for example)
Alzheimer’s disease along with other co-morbidities (Fig. 7). This
highlights the role of co-morbidities in determining mortality in
patients with SMI and points to the need for multiple conditions
to be treated simultaneously in patients. This also suggests that a
pragmatic trial of robust management of co-morbidities may be
justified.
Interpretability is a major design consideration of machine
learning algorithms applied in healthcare. We made our predic-
tions interpretable by using class-contrastive reasoning and
counterfactual statements6.
This approach has the capability to make some black-box
models explainable, which might be very useful for clinical
decision support systems. We demonstrate the approach here
using logistic regression and artificial neural networks. These
techniques could ultimately be used to build a conversational AI
that could explain its predictions to a clinician.
Our work can also be used to make clinical decision support
systems. This may lead to automated alerts in electronic
healthcare record systems, after thorough validation in follow-up
studies.
Our study is observational in nature and we do not imply
causation. Our data is a naturalistic sample from clinics and should
not be used to alter clinical practice. Our aim is to raise hypotheses
that will need to be tested in randomized controlled trials.
There may also be other unknown confounds and hence causal
conclusions cannot be drawn from an observational study. For
example, a drug that is associated with better outcomes may be
preferred by clinical teams, and a drug that is associated with
poorer outcomes may still be prescribed for severely ill patients
because it is perceived to be effective.
There may also be under-coding of schizophrenia diagnoses.
The data were from a secondary care mental health service
provider and may miss important risk factors coded in
primary care.
Psychiatric diagnoses are challenging and there can be
potential issues related to the reliability of diagnostic categories
in SMI. Sampling bias is another issue in real world electronic
healthcare record data. For example, it is possible that only the
most severely ill patients seek clinical help and/or get referred to
secondary care. Hence the data may reflect a category of patients
who are more severely ill.
Our data also lacks temporal structure, which is likely to be
important in determining progression of disease. The current work
relates observable features to the risk of death within the
observation period. Clearly this is not as satisfactory as a model
that predicts a time-based risk. It would be expected that the
temporal risk conferred by different features would vary—for
example, diabetes increases cardiovascular risk over decades,
whereas delirium is often associated with critical illness and may
be associated with an elevated mortality risk that is very
immediate or proximal. A comprehensive model might involve
autodiscovery of those temporal risk factors, at the price of a
considerable increase in model complexity. This will require
building more complex recurrent neural network models like long
short-term memory models (LSTM), which will require even
more data.
Important readouts like statistical significance cannot be judged
from the class-contrastive heatmaps. For example, lack of family
support appeared to be associated with higher mortality in the
class-contrastive heatmap for the logistic regression model (Fig. 4).
However, this association was not statistically significant, even
though the odds ratio for lack of family support was greater than 1
in a logistic regression model (Fig. 3).
We combined several medications into the category of second-
generation antipsychotics, which itself consists of a heterogenous
group of medications13, and made other simplifications in our
treatment of medications.
Because of heterogeneity in training data and correlations
across features, reproducibility of heatmaps is a limitation. We
show an additional representative example in Supplementary Fig.
1. There are a few differences between these heatmaps
(Supplementary Fig. 1 and Fig. 6). This heatmap is consistent
with previous results (Fig. 6), with the exception that it shows SGA
are associated with an increased probability of mortality
(Supplementary Fig. 1, bottom left arrow). This is not consistent
with previous results from the logistic regression model and
survival analysis for the effect of SGA (Figs. 2 and 3). Reconciling
these results will require additional analysis and validation in an
independent cohort with more patients.
Our results suggest that the class-contrastive approach is
sensitive to the training data and any imbalances in features.
For example, a particular binary feature may be 0 for 100 patients
and 1 for 10 patients. One way to determine this sensitivity is to
artificially introduce more zeros and then observe the class
contrastive heatmaps.
It is possible that the counter-intuitive observations we see in
the class-contrastive heatmaps (on the test set) are likely as a
S. Banerjee et al.
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result of such imbalances in the training set. Because of this,
reproducibility of heatmaps is a limitation of our approach.
Our approach can be helpful when explicit causal structure is
modelled, and when there are binary (categorical) features and a
few features which can be modified at a time. We account for
correlations between features by modifying all pairs of features at
a time and then observing the effect on model predictions (Fig. 7).
However, this approach can become computationally challenging
for higher combinations of features (all triples, quadruples, all
possible combinations), or as the number of features increase.
In conclusion, our framework combines bio-social factors
relevant for SMI with statistical learning, and makes them
interpretable using class-contrastive techniques. Our work sug-
gests that medications like antidepressants were associated with a
reduced risk of death in a group of patients with schizophrenia.
Abuse of alcohol and drugs, and a diagnosis of delirium were risk
factors for death.
Our machine learning models highlight the role of co-
morbidities in determining mortality in patients with SMI and
the need to manage them. We hope that some of these bio-social
factors can be targeted therapeutically by either patient-level or
service-level interventions.
We complement explainable machine learning techniques with
classical statistical analysis like logistic regression, survival models,
and standardised mortality ratios. This may be a prudent and
pragmatic approach for building explainable models in healthcare.
We admit that the distinction between ML models and classical
statistical models (like logistic regression) is artificial. Models lie on
a continuum and a pragmatic approach towards explainable AI
would combine and contrast all of these techniques.
The approach of combining explainable techniques and clinical
knowledge with machine learning approaches may be more
broadly applicable when data scientists need to work closely with
domain experts (clinicians and patients).
Our approach combines clinical knowledge, health data, and
statistical learning, to make predictions interpretable to clinicians
using class-contrastive reasoning. We view our work as a step
towards interpretable AI and personalized medicine for patients
with SMI and potentially other diseases.
METHODS
Overview of Methods
We give a brief overview of our approach in this section. Our approach is
summarised in Fig. 1.
1. We take de-identified data from an electronic patient record system
for mental health.
2. We define a set of high-level features that are in this example time
independent. These include age, diagnostic categories (time-
independent coded diagnosis at any point during the study period),
and medication categories (time-independent prescription of or use
of medications). We also include bio-social factors that are important
in SMI like information on mental health diagnosis, relevant risk
history such as a prior suicide attempt, substance abuse, and social
factors such as lack of family support.
3. We use these features to predict death during the time of
observation.
4. We use classical statistical models including logistic regression,
survival models, and standardised mortality ratios.
5. We then fit machine learning models, comparing predictive
accuracy to the classical statistical models.
6. Class-contrastive heatmaps are used to visualize the explanations of
the statistical models and machine learning predictions. The corre-
sponding class-contrastive statements also aid human interpretation.
Mental health clinical record database
We used data from the Cambridgeshire and Peterborough NHS Founda-
tion Trust (CPFT) Research Database. This comprises electronic healthcare
records from CPFT, the single provider of secondary care mental health
services for Cambridgeshire and Peterborough, UK, an area in which
~856,000 people reside. The records are de-identified using the CRATE
software14 under NHS Research Ethics approval (12/EE/0407, 17/EE/0442).
The CPFT Research Database operates under UK NHS Research Ethics
approvals (REC references 12/EE/0407, 17/EE/0442; IRAS project ID 237953).
Data included patient demographics, mental health and physical co-
morbidity diagnoses: these were derived from coded ICD-10 diagnoses and
analysis of free text through natural language processing (NLP) tools15,16.
Dates of death are automatically updated via the National Health Service
(NHS) Spine. We considered all patients with coded diagnoses of
schizophrenia who had records in the electronic healthcare system from
2013 onwards. There were a total of 1706 patients diagnosed with
schizophrenia defined by coded ICD-10 diagnosis (diagnosis code F20). We
note there is under-coding of schizophrenia.
Medicine information on prescribed drugs
We extracted medicine information for each patient by using natural
language processing on clinical free text data using the GATE software15,17.
Population mortality data
Population mortality data for England and Wales were used from the Office
for National Statistics (ONS)18.
Data input to statistical algorithms
The features fed in to our statistical and machine learning algorithms included
age, gender, high-level diagnosis categories, and medication categories. We
also included other bio-social factors important in SMI. All these features are
used to predict mortality. The full list of features was as follows:
1. High-level medication categories were created based on domain-
specific knowledge from a clinician [RNC]. These medication
categories are:
second-generation antipsychotics (SGA: clozapine, olanzapine, risper-
idone, quetiapine, aripiprazole, asenapine, amisulpride, iloperidone,
lurasidone, paliperidone, sertindole, sulpiride, ziprasidone, zotepine);
first-generation antipsychotics (FGA: haloperidol, benperidol, chlorpro-
mazine, flupentixol, fluphenazine, levomepromazine, pericyazine,
perphenazine, pimozide, pipotiazine, prochlorperazine, promazine,
trifluoperazine, zuclopenthixol); antidepressants (agomelatine, amitrip-
tyline, bupropion, clomipramine, dosulepin, doxepin, duloxetine,
imipramine, isocarboxazid, lofepramine, maprotiline, mianserin, mirta-
zapine, moclobemide, nefazodone, nortriptyline, phenelzine, rebox-
etine, tranylcypromine, trazodone, trimipramine, tryptophan, sertraline,
citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, vortiox-
etine and venlafaxine); diuretics (furosemide); thyroid medication (drug
mention of levothyroxine); antimanic drugs (lithium) and medications
for dementia (memantine and donepezil).
2. Relevant co-morbidities we included were diabetes (inferred from ICD-
10 codes E10, E11, E12, E13 and E14 and any mentions of the drugs
metformin and insulin), cardiovascular diseases (inferred from ICD-10
diagnoses codes I10, I11, I26, I82, G45 and drug mentions of
atorvastatin, simvastatin and aspirin), respiratory illnesses (J44 and
J45) and anti-hypertensives (mentions of the drugs bisoprolol and
amlodipine).
3. We included all patients with a coded diagnosis of schizophrenia (F20).
For these patients with schizophrenia, we also included any additional
coded diagnosis from the following broad diagnostic categories:
dementia in Alzheimer’s disease (ICD-10 code starting with F00),
delirium (F05), mild cognitive disorder (F06.7), depressive disorders
(F32, F33) and personality disorders (F60).
4. We also included relevant social factors: lack of family support (ICD-10
chapter code Z63) and personal risk factors (Z91: a code encompassing
allergies other than to drugs and biological substances, medication
noncompliance, a history of psychological trauma, and unspecified
personal risk factors); alcohol and substance abuse (this was inferred
from ICD-10 coded diagnoses of Z86.4, F10, F12, F17, F19 and
references to thiamine, which is prescribed for alcohol abuse). Other
features included are self-harm (ICD-10 codes T39, T50, X60, X61, X62,
X63, X64, X78 and Z91.5), non-compliance and personal risk factors
(Z91.1), referral to a crisis team at CPFT (recorded in the electronic
healthcare record system) and any prior suicide attempt (in the last
6 months or any time in the past) coded in structured risk assessments.
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These broad categories constituted our representation of simplified
clinician-based knowledge. We used these features (including age of the
patient) to predict whether a patient died any time during the time period
observed (from first referral to CPFT to the present day). We did not
attempt to predict the risk of dying, for instance, 1 year after first referral to
CPFT. The features we used to predict mortality were also time-
independent. This represents a simplified time-independent model. More
detailed modelling would include temporal effects of such predictors.
Age was a predictor in all our models, including survival models. We
consider time of death and time of feature collection. The observed
outcome (death) was binary and this is the outcome the models are
predicting but models do so via a continuous variable related to risk/
probability, so this is simultaneously predicted. Our model predictions, if
independently validated in another clinical setting, could be converted in
to a risk or probability.
All our models, including the machine learning model, include age as a
predictor. However, the class-contrastive analysis and the class-contrastive
heatmaps do not include age since the feature changes (one at a time or
pairwise) can be achieved only for binary (categorical) features. Hence, the
class-contrastive heatmaps show the effect of changing predictors on the
model prediction, over and above the contribution of age.
Data pre-processing
Diagnostic codes were based on the International Classification of Diseases
(ICD-10) coding system19. Age of patients was normalised (feature scaled) by
subtracting the mean age from the age of each patient and then dividing by
the standard deviation. All categorical variables, such as diagnosis and
medications (described above), were converted using a one-hot encoding
scheme. This is explained in detail in the Supplementary section.
Machine learning and statistical techniques
We performed logistic regression using generalized linear models20,21. We
used age (feature scaled) as a continuous predictor. There are categorical
features (medications, co-morbidities and other social and personal
predisposing factors) that were encoded using a one-hot representation.
For our machine learning approach, we used artificial neural networks
(autoencoders) to integrate data from different sources giving a holistic
picture of mental health, physical health and social factors contributing to
mortality in SMI. We use the same set of features for all algorithms.
Artificial neural networks are composed of computational nodes
(artificial neurons) that are connected to form a network. Each artificial
neuron performs a simple computation (much like logistic regression). The
neurons are organised in layers. The input layer takes in the input features,
transforms them, and passes it to one or more intermediate layers called
hidden layers. The hidden layer performs further transformations and
passes the result to the output layer. The final output layer is used to make
a prediction (in this case, about mortality).
The autoencoder is a type of artificial neural network that also performs
dimensionality reduction since the hidden layer has fewer neurons than
the input layer22. In our framework, the reduced dimensions of the
autoencoder (output of the hidden layer) were used as input to a random
forest model to predict mortality (Fig. 5). Random forests are machine
learning models that build collections of decision trees23. Each decision
tree makes a prediction after making a series of choices based on the input
data. These decision trees are combined to build a collection (forest) that
together has better predictive ability than a single tree.
We split the data into a training set (50%), validation set (25%) and test
set (25%). We performed 10-fold cross-validation and regularization to
penalize for model complexity. The architecture is summarised in Fig. 5. We
used the following models to predict mortality:
1. Logistic regression model with all the original input features;
2. An autoencoder with the bio-social features as input. We then use
the reduced dimensions from the autoencoder as input features to a
random forest model (Fig. 5).
Machine learning methods. We used an artificial neural network, called an
autoencoder, to integrate data from different sources and predict
mortality. The input features are age (normalised), gender, diagnosis
categories, lifestyle risk factors, social factors and medication categories.
We used the same set of features for all algorithms.
Categorical features (such as medication categories) are encoded using
a one-hot representation. This involves taking a vector that is as long as the
number of unique values of the feature. Each position on this vector
corresponds to a unique value that the categorical feature can take.
Whenever a categorical feature (say, did a patient take cardiovascular
medication) takes on a particular value (say True), we place a 1 (‘hot’)
corresponding to that position on the vector and 0 everywhere else.
We show the architecture of the autoencoder in Fig. 5. The autoencoder
is an artificial neural network with an input layer, hidden layer and an
output layer. The input layer takes in the bio-social features. The output
layer is used to reconstruct the input. The hidden layer of the autoencoder
is used for dimensionality reduction.
The autoencoder had one hidden layer of 10 neurons. We used the
hidden layer as input to a random forest model to predict mortality. A
similar architecture was applied previously to electronic healthcare record
data24. The choice of an autoencoder allows reduction of the feature space.
An artificial neural network has an input layer, hidden layer(s) and
output layer. An activation function is used to project the input data (X)
into another feature space using weights (W).
f ðW  XÞ (1)
The weights W are determined from data using a technique called
backpropagation25.
We used a ReLU (Rectified Linear Unit) activation function for the hidden
layer. The form of the ReLU function is shown below:
f ðxÞ ¼ maxð0; xÞ (2)
We used a sigmoid activation function for the final layer:
f ðxÞ ¼ 1
1þ ex (3)
The output of the sigmoid function is positive even for negative input.
We also experimented with a hyperbolic tangent (tanh) function shown
below:
f ðxÞ ¼ e
x  ex
ex þ ex (4)
However, the cross-validation results (see discussion later) were inferior
to that of the ReLU activation function.





logðPðY ¼ yi jxi ; θÞÞ þ λjjθjj (5)
This is the negative log-likelihood. There are d data points. The i th data
point has a label denoted by yi and input feature vector represented by xi.
The weights of the artificial neural network are represented by a vector θ. λ
is a regularization parameter to prevent overfitting and reduce model
complexity. λ is usually determined by cross-validation. Shown here is the
L1 norm of the parameter vector (θ). The weights of the artificial neural
network are determined using a technique called backpropagation25.
The autoencoder used a cross-entropy loss function, which is a measure
of discrepancy between the input layer and the reconstructed hidden




uk log vk þ ð1 ukÞlog ð1 vkÞ (6)
where there are m features in the input layer. u represents the input layer
and v represents the hidden layer. The layers are computed by applying
the appropriate activation functions (Equations (1), (2) and (3)).
The final cost function is given below:
Xm
k¼1
uk log vk þ ð1 ukÞlog ð1 vkÞ þ λjjθjj (7)
where the vector θ represents all the weights of the artificial neural
network. There are m features in the input layer. u represents the input
layer and v represents the hidden layer. We added an L1 penalty term on
the weights to perform regularization and prevent overfitting. This is
denoted by the term λ∣∣θ∣∣. λ is a regularization parameter that we
determined by 10-fold cross-validation.
S. Banerjee et al.
11
Published in partnership with the Schizophrenia International Research Society npj Schizophrenia (2021)    60 
We performed a 50%–25%–25% training-validation-test split of the data.
We used the keras package26 with the Tensorflow backend27.
The artificial neural network was trained on the training data for a number
of epochs. In one epoch the network is trained on the training dataset. The
model fit is then refined over subsequent epochs. Our neural network was
trained for 1000 epochs, which was assessed as being sufficient to reach
convergence. We used the Adadelta method of optimization28.
We selected all hyperparameters, including the number of neurons in a
hidden layer and activation functions, based on a uniform search and 10-fold
cross-validation. We split the data into a training set (50%), validation set
(25%), and test set (25%). We trained the model on the training set. We carried
out cross-validation on the validation set. The architectural parameters and
regularization parameters were then selected. This final model was then
evaluated on the test set. This process of splitting the data (into training,
validation and test sets), training the model and performing cross-validation
was repeated 10 times.
We varied the number of neurons in the hidden layer from 2 to 20. For
activation functions, we tried sigmoid, rectified linear unit (ReLU) and
hyperbolic tangent (tanh). We do not use dropout regularization to keep a
simple architecture and simplify the process of model selection. A hidden
layer of 10 neurons and ReLU and sigmoid activation functions (for the first
and second layers, respectively), were found to have the least cross-
validation error.
We repeated the stochastic process of splitting the data into training and
test sets and performing cross-validation 10 times. This yielded a mean AUC of
0.80 (95% confidence intervals [0.78, 0.82]).
Class-contrastive reasoning
We explain our models using class-contrastive reasoning and class-
contrastive heatmaps. The technique works as follows. The model is
trained on the training set. For each patient in the test set, we
independently mutate (change from 0 to 1, or 1 to 0) each categorical
feature. For each patient in the test set, we use the trained model to
compute the change in the predicted probability of death.
We repeat this procedure independently for each feature and each
patient in the test set. We do not retrain the model when we mutate the
features. The predictions are made using the trained machine learning
model on the test set.
We visualize the amount of change in the model predicted probability of
mortality, achieved by setting a particular feature to 1 versus 0, using a
class-contrastive heatmap. The rows represent patients and columns
represent the feature that has been changed from 0 to 1. The heatmaps
also show a hierarchical clustering dendrogram, which is performed using
an Euclidean distance metric and complete linkage23.
In another variant, we also simultaneously change all pairs of features in the
test set from 0 and 0 to 1 and 1. As before, for each patient in the test set, we
use the trained model to compute the change in the predicted probability of
death. In this case, the class-contrastive heatmap shows the amount of
change in the predicted probability of mortality, achieved by setting a
particular combination of features to 1 versus 0. The rows represent patients
and columns represent the combination of features that are changed
simultaneously.
The class-contrastive heatmap shows patient-specific predictions.
Predictions for individual patients are made in the following way: the
trained model makes a prediction for the probability of death based on the
modified features as input. This process is repeated for each patient and
each feature (or feature combination).
Survival analysis and standardized mortality ratios
For survival analysis, we used the entry date (exposure) as the date of
referral. In cases where there were multiple referrals for a patient, we
considered the earliest date. If this calculated date was earlier than the
start date of our mental health clinical database (called RiO), we set it to
the start date of RiO (1st December 2012). The event was death. The date
of death was derived from the National Health Service (NHS) Spine.
We used a Cox proportional hazards model for patients with
schizophrenia, using age (feature scaled) and the bio-social features (as
outlined before) as input features.
Standardized mortality ratios (SMR) are a method to standardize and
control for age and population structure29. We calculated age-standardized
mortality ratios (SMR) to standardize and control for age and population
structure. For calculating SMRs, we defined five-year age groups (0–4, 5–9,
..., 85–90, and >90 years). Population mortality data was used from the
Office for National Statistics (ONS)18.
We calculated SMRs using the indirect method of standardization29. The
denominator is the expected number of deaths in the study population and
the numerator is the number of observed deaths in the study population.
Hence the indirectly standardized SMR is the ratio of the number of
deaths observed in a study population to the number expected if the age-




where d is the number of deaths in the study population. Say there are k
age groups in the study and standard population. ni is the number of
people in the ith group of the study population and Ri is the crude death
rate in the ith group of the standard population. The 95% confidence







Here O is the observed number of deaths in the study population and E
is the expected number of deaths in the study population.
Logistic regression models
We used a logistic regression model to predict mortality in patients with
schizophrenia. Age (feature scaled) and the bio-social factors were used as
input. The model, in R notation, was as follows:
Death ~ age+ dementia+ delirium+ abuse_alcohol_drugs+ specific_per-
sonality_disorder+ respiratory+ cardiovascular+ diabetes+ self_harm+
lack_family_support+ personal_risk_factors+ SGA+ antidepressant+ suici-
de_attempt+ dementia_drug+ antimanic_drug+ thyroid+ FGA+ diuretic
+ anti_hypertensive+ aspirin.
This same model was also fitted using an L1 regularized logistic
regression model (details are available in the Supplementary section,
subsection Sensitivity analysis).
We also fitted a logistic regression model with main effects and an
interaction term between dementia in Alzheimer’s disease and cardiovas-
cular disease. The model, in R notation, was as follows:
Death ~ dementia * cardiovascular+ age+ dementia+ delirium+ abu-
se_alcohol_drugs+ specific_personality_disorder+ respiratory+ cardiovascu-
lar+ diabetes+ self_harm+ lack_family_support+ personal_risk_factors+
SGA+ antidepressant+ suicide_attempt+ dementia_drug+ antimanic_drug
+ thyroid+ FGA+ diuretic+ anti_hypertensive+ aspirin.
Software
All software was written in the R30 and Python programming languages.
Generalized linear model (GLM) regression was performed using the glm
function in R21,31. Hierarchical clustering and visualization were performed
using heatmaps in the pheatmap package32. Survival analysis was
conducted using the survminer package in R33. L1 regularized logistic
regression was performed using the glmnet package34.
Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
DATA AVAILABILITY
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